NASDAQ · Financial Statements

Chinook Therapeutics, Inc. (KDNY) Financial Statements

$40.39 NASDAQ: KDNY Market Cap $2.71B

Chinook Therapeutics, Inc. most recently reported annual revenue of $6.0M, net profit of $-185.0M, revenue has compounded at -18.8% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202020212022
Revenue$15.0M$17.0M$1.0M$52.0M$6.0M
Operating Profit$-101.0M$-20.0M$-56.0M$-99.0M$-185.0M
Net Profit$-95.0M$-47.0M$-82.0M$-101.0M$-185.0M
EPS$0.00$-1.11$-6.20$-2.22$-2.87
Op Margin-671.8%-115.7%-6798.9%-191.8%-3020.3%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$358.0M$16.0M$429.0M$564.0M$574.0M
Total Liabilities$222.0M$57.0M$94.0M$110.0M$132.0M
Cash$126.0M$11.0M$188.0M$182.0M$115.0M
Borrowings$0$2.0M$42.0M$44.0M$39.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-69.0M$-14.0M$-56.0M$-103.0M$-117.0M
Investing Cash Flow$37.0M$-2.0M$109.0M$-115.0M$-102.0M
Financing Cash Flow$-1.0M$1.0M$124.0M$210.0M$151.0M
Net Cash Flow$-31.0M$-115.0M$178.0M$-6.0M$-66.0M
Free Cash Flow$-71.0M$-14.0M$-57.0M$-105.0M$-119.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.21
EV / EBITDA-16.03
FCF Yield-4.40%
Quick Ratio7.59
Interest Coverage-25.78
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
KDNY Overview KDNY Dividend Run Stock Screener